Friday, June 20, 2014 2:31:08 PM
Maybe K&L Gates and the higher powers advised Peregrine that its unethical to announce a possible BTD or two or further make any announcements till the time is right and manufacturing is the #1 concern
Get your manufacturing up to top notch speed, ramp up production of Bavi big time..... before you even think about describing the MOA of Bavi and having everyone calling, looking for it...
Maybe the FDA and the higher powers do not want any monopoly to take form and the only way to avoid that is open up Bavi to all ( .. just do a few more combination trials while manufacturing ramps up, while March Madness follows, while you give your KOL's time to explain to the industry what is about to happen...
All hell breaking loose asking for their Bavi and the FDA and the higher powers are like that Walmart opening up at midnight after Thanksgiving and everyone looking for the hottest immunotherapy treatment around.. except no sales in Tustin for no one.
BMS ? CALICO ? ...anyone ? ironically.... maybe the FDA told all the competition to STFU lol : ) and they will all have their equal chance at Bavi when the time is right
so what do they do ? They all start to go on M/A and buying sprees... but the problem is, no one wants to sell ( a couple asset swaps..etc) but they know the cancer immunotherapy market is just about to be lit up for many years to come and those Billions of revenues are about to improve big time
"Bavituximab is a first-in-class phosphatidylserine (PS)-targeting monoclonal antibody that is the cornerstone of a broad clinical
pipeline." -- Big Pharmas nightmare... unless they are fortunate enough to have The Bavi Edge!
Recent CDMO News
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 12/23/2024 09:24:31 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 12/20/2024 09:31:45 PM
- Avid Bioservices Recommends Stockholders Vote FOR Value Maximizing Transaction • GlobeNewswire Inc. • 12/18/2024 09:35:00 PM
- Form DEFM14A - Definitive proxy statement relating to merger or acquisition • Edgar (US Regulatory) • 12/18/2024 09:13:49 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/18/2024 12:50:13 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/18/2024 12:49:09 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/18/2024 12:48:42 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/18/2024 12:47:53 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/18/2024 12:47:15 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/18/2024 12:46:46 AM
- Form SC 13G - Statement of Beneficial Ownership by Certain Investors • Edgar (US Regulatory) • 12/13/2024 03:53:25 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 12/10/2024 10:08:34 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/10/2024 10:00:13 PM
- Avid Bioservices Reports Financial Results for Second Quarter Ended October 31, 2024 • GlobeNewswire Inc. • 12/10/2024 09:05:23 PM
- Form PREM14A - Preliminary proxy statements relating to merger or acquisition • Edgar (US Regulatory) • 12/03/2024 10:04:32 PM
- Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend] • Edgar (US Regulatory) • 11/15/2024 12:53:01 AM
- Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend] • Edgar (US Regulatory) • 11/12/2024 09:15:31 PM
- Rowley Law PLLC is Investigating Proposed Acquisition of Avid Bioservices, Inc. • PR Newswire (US) • 11/07/2024 10:55:00 PM
- Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material • Edgar (US Regulatory) • 11/07/2024 02:59:47 AM
- Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material • Edgar (US Regulatory) • 11/07/2024 02:42:14 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/07/2024 02:11:21 AM
- Avid Bioservices to be Acquired by GHO Capital Partners and Ampersand Capital Partners in $1.1 Billion Transaction • GlobeNewswire Inc. • 11/06/2024 11:04:07 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/17/2024 08:45:52 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 10/15/2024 11:40:21 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 10/11/2024 11:38:34 PM
Hertz Energy Provides Antimony and Critical Minerals Projects Update and Announces Financing • HZLIF • Dec 20, 2024 9:00 AM
North Bay Resources Announces Arrival of 42 Tons Gold Ore at Bishop Gold Mill, California • NBRI • Dec 20, 2024 9:00 AM
Consumer Automotive Finance Subsidiary Drago Knives Narrows Down Potential Partner to Manufacture Patented Throwing Knives • CAFI • Dec 20, 2024 9:00 AM
$ASNS - Is this the Next Big Cybersecurity Stock? How Actelis Networks is Revolutionizing Critical Infrastructure Protection • ASNS • Dec 20, 2024 8:50 AM
UAV Corp's (UMAV), Skyborne Technology to Build "SKY" Hangar at Its Costin Airport Scheduled for Groundbreaking Ceremony Winter 2025 • UMAV • Dec 20, 2024 8:30 AM
UAV Corp. (UMAV) Reduces Authorized Shares by 1.2 Billion, Demonstrating Commitment to Shareholders; New Authorized Share Count Approved at 800 Million • UMAV • Dec 17, 2024 12:00 PM